(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 0.91% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 72.18%.
Thermo Fisher Scientific's revenue in 2023 is $44,167,000,000.On average, 7 Wall Street analysts forecast TMO's revenue for 2023 to be $17,479,331,580,429, with the lowest TMO revenue forecast at $17,185,808,503,615, and the highest TMO revenue forecast at $17,851,565,167,969.
In 2024, TMO is forecast to generate $18,613,502,301,940 in revenue, with the lowest revenue forecast at $18,606,133,731,815 and the highest revenue forecast at $18,620,772,823,175.